C. Power

发表

International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

A. Mantovani, K. Matsushima, M. Thelen, 2014, Pharmacological Reviews.

A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock

Yolande Chvatchko, F. Conquet, P. Juillard, 2000, The Journal of experimental medicine.

Chemokine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

A. Mantovani, K. Matsushima, M. Thelen, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Chemokine receptors (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database

A. Mantovani, M. Rosenkilde, K. Matsushima, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

International union of pharmacology. XXII. Nomenclature for chemokine receptors.

K. Matsushima, M. Baggiolini, I. Charo, 2000, Pharmacological reviews.

Protein therapeutics – lessons learned and a view of the future

J. Shaw, C. Power, A. Proudfoot, 2006, Expert opinion on biological therapy.

Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line (*)

C. Power, A. Proudfoot, K. Bacon, 1995, The Journal of Biological Chemistry.

Characterization of the Chemokine CXCL11-Heparin Interaction Suggests Two Different Affinities for Glycosaminoglycans*

Ariane L. Jansma, T. Handel, C. Power, 2010, The Journal of Biological Chemistry.

Definition, function and pathophysiological significance of chemokine receptors.

C. Power, A. Proudfoot, T. Wells, 1998, Trends in pharmacological sciences.

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

T. Schwartz, M. Rosenkilde, I. Clark-lewis, 1997, Science.

A Member of the Dendritic Cell Family That Enters B Cell Follicles and Stimulates Primary Antibody Responses Identified by a Mannose Receptor Fusion Protein

S. Gordon, M. Kosco‐Vilbois, C. Power, 1999, The Journal of experimental medicine.

Ticks produce highly selective chemokine binding proteins with antiinflammatory activity

M. Teixeira, J. Shaw, G. Graham, 2008, The Journal of experimental medicine.

A chimeric MIP‐1α/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors

M. Parmentier, M. Mack, C. Blanpain, 2001, Journal of leukocyte biology.

Solid-phase binding assay to study interaction of chemokines with glycosaminoglycans.

R. Hubbard, C. Power, A. Hoogewerf, 1997, Methods in enzymology.

Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets.

M. Baggiolini, C. Power, A. Proudfoot, 2000, Blood.

IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D.

D. Taub, B. Premack, T. Schall, 1995, Journal of immunology.

Molecular Cloning and Characterization of a Highly Selective Chemokine-binding Protein from the Tick Rhipicephalus sanguineus*

M. Teixeira, J. Silva, C. Power, 2007, Journal of Biological Chemistry.

Multi-faceted strategies to combat disease by interference with the chemokine system.

M. Schwarz, C. Power, A. Proudfoot, 2005, Trends in immunology.

Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models

C. Power, A. Proudfoot, Pauline Bonvin, 2013, The FEBS journal.

in Human Neutrophils γ by IFN- Induction of Chemotaxis to CC Chemokines Up-Regulation of CCR1 and CCR3 and

C. Mackay, A. Mantovani, S. Bernasconi, 2013 .

Anti-chemokine small molecule drugs: a promising future?

M. Schwarz, C. Power, A. Proudfoot, 2010, Expert opinion on investigational drugs.

CHEMOKINES, CC | RANTES (CCL5)

C. Power, A. Proudfoot, Z. Johnson, 2006 .

Cellular Assays of Chemokine Receptor Activation

M. Mack, C. Power, A. Proudfoot, 2001, Current protocols in pharmacology.

Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors*

R. Offord, C. Power, A. Proudfoot, 1999, The Journal of Biological Chemistry.

Up-Regulation of CCR1 and CCR3 and Induction of Chemotaxis to CC Chemokines by IFN-g in Human

C. Mackay, A. Mantovani, S. Bernasconi, 1999 .

Strategies for chemokine antagonists as therapeutics.

C. Rommel, C. Power, A. Proudfoot, 2003, Seminars in immunology.

CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4

R. Doms, J. Hoxie, M. Endres, 1996, Cell.

A fluorescent interleukin-8 receptor probe produced by targetted labelling at the amino terminus.

J. Mermod, H. Gaertner, C. Power, 1995, European journal of biochemistry.

The chemokine system: novel broad-spectrum therapeutic targets.

C. Power, A. Proudfoot, Amanda E. I. Proudfoot, 2001, Current opinion in pharmacology.

Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*)

M. Montjovent, R. Offord, C. Power, 1996, The Journal of Biological Chemistry.

Chemokines as drug targets

M. Schwarz, C. Power, A. Proudfoot, 2007 .

Expression of intercellular adhesion molecule 1 (ICAM-1) on human articular cartilage chondrocytes.

J. Dingle, C. Power, R. Pigott, 1991, Connective tissue research.

Chemokine receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

A. Mantovani, M. Rosenkilde, K. Matsushima, 2020 .

Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ mice

S. Kunkel, C. Hogaboam, C. Power, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Targeting chemokines: Pathogens can, why can't we?

C. Power, A. Proudfoot, Pauline Bonvin, 2015, Cytokine.

Structural and functional studies of the endothelial activation antigen endothelial leucocyte adhesion molecule-1 using a panel of monoclonal antibodies.

L. Needham, C. Power, R. Pigott, 1991, Journal of immunology.

Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice.

C. Power, A. Proudfoot, A. Hoogewerf, 1997, Immunology letters.

The effect of genotoxic compounds on the fidelity of DNA synthesis

C. Power, 1983 .

Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines.

M. Gobbi, P. Allavena, A. Mantovani, 1997, Journal of immunology.

Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4.

C. Power, A. Proudfoot, A. Hoogewerf, 1996, Biochemical and biophysical research communications.

A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations

James J. Campbell, P. Kivisäkk, E. S. Baekkevold, 2005, The Journal of experimental medicine.

Chemokine and chemokine receptor mRNA expression in human platelets.

C. Power, T. Wells, K. Clemetson, 1995, Cytokine.

Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs.

I. Adcock, T. Williams, P. Jose, 1994, Biochemical and biophysical research communications.

Evasins: Tick Salivary Proteins that Inhibit Mammalian Chemokines

S. Bhattacharya, M. Stone, C. Power, 2020, Trends in biochemical sciences.

Characterisation of the RANTES/MIP‐1α receptor (CC CKR‐1) stably transfected in HEK 293 cells and the recombinant ligands

M. Montjovent, C. Power, A. Proudfoot, 1995, FEBS letters.

Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets.

C. Power, T. Wells, R. Furness, 1994, Gene.

Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258

C. Power, Valéria Szijártó, Luis M Guachalla, 2017, Virulence.

Cloning and Characterization of a Novel Murine Macrophage Inflammatory Protein-1α Receptor*

A. Coyle, C. Power, A. Proudfoot, 1996, The Journal of Biological Chemistry.

Anti-bacterial Monoclonal Antibodies.

C. Power, Valéria Szijártó, E. Nagy, 2017, Advances in experimental medicine and biology.

Chapter 2.2 – Chemokines

J. Shaw, C. Power, A. Proudfoot, 2002 .

Chemokine receptors and their role in leukocyte activation.

C. Power, A. Proudfoot, T. Wells, 1999, Immunology letters.

CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafﬁcking to Inﬂamed Skin

James J. Campbell, E. Butcher, C. Power, 2001 .

Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen

C. Power, D. Simmons, R. Pigott, 1990, The Journal of experimental medicine.

CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin

James J. Campbell, E. Butcher, C. Power, 2001, The Journal of experimental medicine.

Development of an Integrated Qualitative and Quantitative Approach to Study Expression- Secretion Bottlenecks of Mammalian cDNAs in HEK293 EBNA Cells

C. Power, G. Feger, T. Battle, 2007 .

Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.

R. Hubbard, C. Power, A. Proudfoot, 1999, Biochemistry.

Low serum immunoglobulin concentrations in related Weimaraner dogs.

C. Power, M. Day, J. Oleshko, 1997, The Journal of small animal practice.

Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3α from Lung Dendritic Cells

A. Mantovani, S. Sozzani, C. Power, 1997, The Journal of experimental medicine.

Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines.

M. Peitsch, C. Power, S. Alouani, 1997, European journal of biochemistry.

Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion

A. Trkola, John P. Moore, C. Power, 1999, Journal of Virology.

Cloning and characterization of human chemokine receptors.

C. Power, T. Wells, 1996, Trends in pharmacological sciences.

Chemokine inhibition--why, when, where, which and how?

C. Rommel, H. Ji, T. Ruckle, 2004, Biochemical Society transactions.

Glycosaminoglycans mediate cell surface oligomerization of chemokines.

C. Power, A. Proudfoot, F. Borlat, 1997, Biochemistry.

Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.

C. Mackay, A. Mantovani, S. Bernasconi, 1999, Journal of immunology.

Induction of γ-glutamyl transpeptidase mRNA by aflatoxin B1 and ethoxyquin in rat liver

G. Guellaen, M. Manson, C. Power, 1987 .

Chemokine blockers--therapeutics in the making?

J. Shaw, C. Power, A. Proudfoot, 2006, Trends in pharmacological sciences.

Chemokine receptors - the new frontier for AIDS research.

M. Marsh, C. Power, A. Proudfoot, 1996, Chemistry & biology.

The strategy of blocking the chemokine system to combat disease

C. Power, A. Proudfoot, T. Wells, 2000, Immunological reviews.

CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages

E. De Clercq, G. Simmons, J. Reeves, 1998, Journal of Virology.

Transformation related expression of glutathione-S-transferase P in rat liver cells.

S. Sinha, G. Neal, M. Manson, 1987, Carcinogenesis.

Selectivity and antagonism of chemokine receptors

M. Peitsch, R. Cooke, C. Chung, 1996, Journal of leukocyte biology.

Identification of the horse epidermal growth factor (EGF) coding sequence and its use in monitoring EGF gene expression in the endometrium of the pregnant mare.

L. Amet, C. Power, W. Allen, 1994, Journal of molecular endocrinology.

Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes

A. Sica, A. Mantovani, S. Sozzani, 1997, The Journal of experimental medicine.

Strategies to interfere with the chemokine network in disease.

C. Power, A. Proudfoot, T. Wells, 1999, Chemical immunology.

Properties of 7ND-CCL2 are modulated upon fusion to Fc.

M. Mack, C. Power, A. Proudfoot, 2012, Protein engineering, design & selection : PEDS.

GlialCAM, an immunoglobulin‐like cell adhesion molecule is expressed in glial cells of the central nervous system

U. Boschert, B. Antonsson, C. Power, 2008, Glia.

Assessing the function of pneumococcal neuraminidases NanA, NanB and NanC in in vitro and in vivo lung infection models using monoclonal antibodies

Harald Rouha, C. Power, M. Caccamo, 2018, Virulence.

Evasins: Therapeutic Potential of a New Family of Chemokine-Binding Proteins from Ticks

C. Power, A. Proudfoot, Pauline Bonvin, 2016, Front. Immunol..

Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3

J. Shaw, C. Power, A. Proudfoot, 2009, PloS one.

Knock out models to dissect chemokine receptor function in vivo.

C. Power, 2003, Journal of immunological methods.

Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets.

C. Power, A. Proudfoot, K. Bacon, 1994, European journal of biochemistry.

Mutation of Leu25 and Val27 Introduces CC Chemokine Activity into Interleukin-8 (*)

J. Mermod, B. Allet, C. Power, 1995, The Journal of Biological Chemistry.

MIG—differential gene expression in mouse brain endothelial cells

J. Colinge, A. Salmaggi, C. Power, 2002, Neuroreport.

Chemokine receptors in GtoPdb v.2023.1 Chemokine receptors in GtoPdb v.2023.1

A. Mantovani, K. Matsushima, M. Thelen, 2023 .

Purification of human lung dendritic cells by three color flow cytometry.

J. Bonnefoy, C. Power, J. Aubry, 1995, Advances in experimental medicine and biology.

Interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers.

C. Power, K. Bacon, T. Wells, 1994, Immunology.

Chemokines in Rheumatoid Arthritis

J. Vencovský, C. Power, C. Plater‐Zyberk, 1999 .

Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display*

T. Handel, J. Shaw, C. Power, 2014, The Journal of Biological Chemistry.

The Molecular Basis of Selectivity Between CC and CXC Chemokines: The Possibility of Chemokine Antagonists as Anti‐inflammatory Agents

M. Peitsch, C. Chung, C. Power, 1996, Annals of the New York Academy of Sciences.

Crystallization and preliminary X-ray diffraction studies of human RANTES.

G. Kryger, A. Wonacott, J. Shaw, 1994, Journal of molecular biology.

Structure and Bioactivity of Recombinant Human CTAP-III and NAP-2

M. Peitsch, J. Mermod, B. Allet, 1997, Journal of protein chemistry.

CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry.

R. Weiss, C. Power, S. Talbot, 1997, Virology.

Generation of stable cell lines expressing chemokine receptors.

C. Power, A. Meyer, 2000, Methods in molecular biology.

Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display*

T. Handel, J. Shaw, C. Power, 2014, The Journal of Biological Chemistry.

A Member of the Dendritic Cell Family That Enters B Cell Follicles and Stimulates Primary Antibody Responses Identified by a Mannose Receptor Fusion Protein

S. Gordon, C. Power, L. Martínez-Pomares, 1999, The Journal of experimental medicine.

International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

K. Matsushima, M. Thelen, R. Nibbs, 2014, Pharmacological Reviews.

Cloning and characterization of a novel murine macrophage inflammatory protein-1 alpha receptor.

A. Coyle, C. Power, A. Proudfoot, 1996, The Journal of biological chemistry.

Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein

J. Hoxie, C. Power, P. Klasse, 1997, Journal of virology.

Chemokine receptor antagonist development.

Aurélie Hermant, C. Power, A. Proudfoot, 2013, Methods in molecular biology.